8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome

British Journal of Ophthalmology

Volumn 87, Issue 3, 2003, Pages 353-356

  Koliakos, G G ^a   Konstas, A G P ^b   Schlotzer Schrehardt U ^c   Hollo, G ^d   Katsimbris, I E ^e   Georgiadis, N ^b   Ritch, R ^f  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e Department of Ophthalmology   (Greece)

^f NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ASCORBIC ACID; FREE RADICAL; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIOXIDANT; DRUG DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2 ALPHA; SCAVENGER;

AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EXFOLIATION SYNDROME; HUMAN; IMMUNOASSAY; OXIDATIVE STRESS; PHACOEMULSIFICATION; PRIORITY JOURNAL; CHEMISTRY; CLINICAL TRIAL; METABOLISM; METHODOLOGY; MULTICENTER STUDY; PROSPECTIVE STUDY;

ANTIOXIDANTS; AQUEOUS HUMOR; ASCORBIC ACID; CATARACT; DINOPROST; EXFOLIATION SYNDROME; F2-ISOPROSTANES; FREE RADICAL SCAVENGERS; HUMANS; IMMUNOASSAY; OXIDATIVE STRESS; PROSPECTIVE STUDIES;

EID: 0037332408     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.3.353     Document Type: Article

References (45)

1. Ritch R. Exfolialion syndrome. Curr Opin Ophthalmol 2001;12:124-30.
2. Ritch R, Schlatzer-Schrehardt U. Exfaliation syndrome. 5urv Ophthalmol 2001;45:265-315.
3. Konstas AG, Marshall GE, Lee WR. Immunogold localisation of laminin in normal and exfoliative iris. Br J Ophthalmol 1990;74:450-7.
4. Taylor HR. Pseudoexfoliation, an environmental disease? Trans Ophthalmol Soc UK 1979;99:302-7.
5. Borcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996;10:1077-83.
6. Cejkova J, Lojda Z. The opearance of active plasminogen activator of urokinase type (u-PA) in the rabbit anterior eye segment irradiated by UVB rays. A histochemical and biochemical study. Acta Histochem 1995;97:257-62.
7. Cejkova J, Lajda Z. The damaging effect of UV rays below 320nm on the rabbit anterior eye segment il. Enzyme histachemical changes and plasmin activity after prolonged irradiation. Acta Histochem 1995;97:183-262.
8. Koliakos GG, Konstas AG, Triantos A, et al. Increased growth factor activity in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2000;238:491-5.
9. Schlotzer-Schrehardt U, Zenkel M, Lommatzsch J, et al. Altered balance between matrix metalloproteinasses and their inhibitors in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. ARVO meeting 2002.
10. order WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
11. Koliakos GG, Schlatzer-Schrehardt U, Konstas AG, et al. Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2001;239:482-7.
12. Schlätzer-Schrehardt U, Zenkel M, Küchle M, et al. Role of transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2001;73:765-80.
13. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, et al. Hydrogen peroxide increases extracellulor matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 2001;59:87-95.
14. Weiss MF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001;37:970-80.
15. Ringvold A. The significance of ascorbate in lhe aqueous humour pratection against UV-A and UV-B. Exp Eye Res 1996;62:261-4.
16. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-13.
17. Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 2000;32:377-85.
18. Morrow JD, Awad JA, Boss HJ, et al. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 1992;89:10721-5.
19. Fukunago M, Makita N, Roberts LJ, el al. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264:C1619-24.
20. Prince AM, Streeten BW, Ritch R, et al. Preclinical diagnosis af pseudaexfaliation syndrome. Arch Ophthalmol 1987;105:1076-82.
21. Shichi H, Page T, Sahauri MJ, et al. Microplate assay of ascorbic acid in aqueous humor with bicinchoninic acid. J Ocul Pharmacol Ther 1997;13:201-6.
22. Koliakos GG, Konstas AG, Schlotzer-Schrehardt U, et al. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 2002; (in press).
23. Kuchle M, Ho TS, Nguyen NX, et al. Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest Ophthalmol Vis Sci 1994;35:748-52
24. Roberts LJ, Morrow JD. The isoprostanes: novel markers of lipid peroxidation and potential mediators of oxidant injury. Adv Prostaglandin Thromboxane Leukot Res 1995;23:219-24.
25. Pratico D, FitzGerald GA. Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate praduction by reactive oxygen species and prostoglandin endoperoxide synthase-2. J Biol Chem 1996;271:8919-24.
26. Vanharanta M, Vautilainen S, Nurmi T, et al. Association between low serum enterolactone and increased plasma F(2)-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 2002;160:465-9.
27. Morrow JD, Roberts LJ. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999;300:3-12.
28. Pratico D, Barry OP, Lawson JA, et al. IPF2alpha-1: an index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998;95:3449-54.
29. Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostoglandins wilh canstrictor effects an cerebral arterioles. Stroke 1997;28:844-9.
30. Yura T, Fukunaga M, Khan R, et ol. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999;56:471-8.
31. Lahaie I, Hardy P, Hou X, et al. A novel mechanism far vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol 1998;274:R1406-16.
32. Berger TM, Polidari MC, Dabbagh A, et al. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 1997;272:15656-60.
33. Haas JA, Krier JD, 8olterman RJ, et al. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 1999;34:983-6.
34. Rose RC, Richer SP, 8ode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp 8iol Med 1998;217:397-407.
35. Ringvold A. Quenching of UV-induced fluorescence by ascorbic acid in the aqueous humour. Acta Ophthalmol Scand 1995;73:529-33.
36. Richer SP, Rose RC. Water soluble antioxidants in mammalian aqueous humor: interaction with UV 8 and hydrogen peroxide. Vis Res 1998;38:2881-8.
37. Forsius H. Exfoliation syndrome in various ethnic populations. Acta Ophthalmol Suppl 1988;184:71-85.
38. Montero A, Munger KA, Khan RZ, et al. F(2)-isoprostanes mediote high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int 2000;58:1963-72.
39. Staff AC, Ronheim T, Henriksen T, et al. 8-Iso-prostaglandin f(2alpha) reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension 2000;35:1307-13.
40. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297-306.
41. Kahler J, Ewert A, Weckmuller J, et al. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol 2001;38:49-57.
42. Shimizu T. Changes of iris vessels in capsular glaucoma: three-dimensional and electron microscopic studies. Jpn J Ophthalmol 1985;29:434-52.
43. Vannas A. Flurescein ongiography of the vessels of the iris in pseudoexfoliation of the lens capsule, capsular glaucoma and some other forms af glaucoma. Acta Ophthalmol Suppl 1969;105:9-75.
44. Konstas AG, Marshall GE, Lee WR. Iris vosculapathy in exfoliotion syndrome. An immunocytochemicol study. Acta Ophthalmol (Copenh) 1991;69:472-83.
45. Konstos AG, Marshall GE, Cameran SA, et al. Morphology of iris vasculopathy in exfoliatian glaucoma. Acta Ophthalmol (Copenh) 1993;71:751-9.